This is inconsistent with the findings of Mraz et al. (86) that Foxp1 expression from CLL cells is reduced in patients with relatively high-level compared with low-level expression of miR-150, whereas, Myb expression stay at the low level that is not proportional to miR-150. Here, FOXP1 is linked to B-cell chronic lymphocytic leukemia.